Jörg Czech

1.7k total citations
33 papers, 1.3k citations indexed

About

Jörg Czech is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Jörg Czech has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Hematology and 7 papers in Organic Chemistry. Recurrent topics in Jörg Czech's work include Blood Coagulation and Thrombosis Mechanisms (11 papers), Glycosylation and Glycoproteins Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jörg Czech is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (11 papers), Glycosylation and Glycoproteins Research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Jörg Czech collaborates with scholars based in Germany, France and United States. Jörg Czech's co-authors include Klaus Bosslet, Ramachandra Naik, Peter J. Worland, Edward A. Sausville, H.H. Sedlacek, Dieter Hoffmann, M Stetler-Stevenson, Gurmeet Kaur, Catherine E. Myers and H.H. Sedlacek and has published in prestigious journals such as Angewandte Chemie International Edition, JNCI Journal of the National Cancer Institute and Analytical Biochemistry.

In The Last Decade

Jörg Czech

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Czech Germany 16 712 495 222 170 163 33 1.3k
Jeffrey R. Simard Germany 22 1.5k 2.1× 533 1.1× 386 1.7× 241 1.4× 250 1.5× 42 2.0k
Zoltán Greff Hungary 13 1.0k 1.5× 312 0.6× 225 1.0× 281 1.7× 107 0.7× 21 1.5k
Richard A. Norman United Kingdom 18 1.0k 1.4× 269 0.5× 325 1.5× 91 0.5× 82 0.5× 26 1.5k
Ellen M. Dobrusin United States 16 893 1.3× 608 1.2× 513 2.3× 128 0.8× 257 1.6× 24 1.5k
Yiqun Li China 9 866 1.2× 681 1.4× 242 1.1× 229 1.3× 465 2.9× 25 1.7k
Michael I. Walton United Kingdom 28 1.7k 2.5× 719 1.5× 308 1.4× 223 1.3× 212 1.3× 49 2.5k
J A Double United Kingdom 15 821 1.2× 523 1.1× 191 0.9× 80 0.5× 181 1.1× 29 1.7k
Paul P. Tamburini United States 27 937 1.3× 538 1.1× 83 0.4× 176 1.0× 51 0.3× 48 2.1k
Melanie Valenti United Kingdom 30 1.7k 2.4× 1.1k 2.1× 383 1.7× 233 1.4× 197 1.2× 61 2.6k
R.J. Skene United States 22 1.4k 1.9× 816 1.6× 485 2.2× 86 0.5× 171 1.0× 34 2.5k

Countries citing papers authored by Jörg Czech

Since Specialization
Citations

This map shows the geographic impact of Jörg Czech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Czech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Czech more than expected).

Fields of papers citing papers by Jörg Czech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Czech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Czech. The network helps show where Jörg Czech may publish in the future.

Co-authorship network of co-authors of Jörg Czech

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Czech. A scholar is included among the top collaborators of Jörg Czech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Czech. Jörg Czech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schreuder, Herman, Holger Hoffmann, Matthias Schiell, et al.. (2016). Isolation, Co-Crystallization and Structure-Based Characterization of Anabaenopeptins as Highly Potent Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa). Scientific Reports. 6(1). 32958–32958. 42 indexed citations
2.
Halland, Nis, Mark Brönstrup, Jörg Czech, et al.. (2015). Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin. Journal of Medicinal Chemistry. 58(11). 4839–4844. 37 indexed citations
3.
Nazaré, Marc, Hans Matter, David W. Will, et al.. (2011). Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein–Ligand Complexes. Angewandte Chemie International Edition. 51(4). 905–911. 41 indexed citations
4.
Nazaré, Marc, Hans Matter, David W. Will, et al.. (2011). Fragment Deconstruction of Small, Potent Factor Xa Inhibitors: Exploring the Superadditivity Energetics of Fragment Linking in Protein–Ligand Complexes. Angewandte Chemie. 124(4). 929–935. 8 indexed citations
5.
Yu, Min, et al.. (2010). A novel HLA-A*03 allele, HLA-A*03:71. Tissue Antigens. 76(4). 331–331. 2 indexed citations
6.
7.
Nazaré, Marc, David W. Will, Hans Matter, et al.. (2004). Factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of neutral P1 substituents. Bioorganic & Medicinal Chemistry Letters. 14(16). 4191–4195. 13 indexed citations
8.
Frank, Michael, Sabine Maier, Harald K. Rau, et al.. (2004). Custom chemical microarray production and affinity fingerprinting for the S1 pocket of factor VIIa. Analytical Biochemistry. 335(1). 50–57. 17 indexed citations
9.
Nazaré, Marc, Hans Matter, Otmar Klingler, et al.. (2004). Novel factor Xa inhibitors based on a benzoic acid scaffold and incorporating a neutral P1 ligand. Bioorganic & Medicinal Chemistry Letters. 14(11). 2801–2805. 11 indexed citations
10.
Nazaré, Marc, David W. Will, Hans Matter, et al.. (2004). Novel factor Xa inhibitors based on a 2-carboxyindole scaffold: SAR of P4 substituents in combination with a neutral P1 ligand. Bioorganic & Medicinal Chemistry Letters. 14(16). 4197–4201. 14 indexed citations
11.
Papot, Sébastien, et al.. (2000). Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard. Bioorganic & Medicinal Chemistry Letters. 10(16). 1835–1837. 11 indexed citations
12.
Czech, Jörg, et al.. (1996). Influence of Recombinant Hirudin on Tissue-Factor-Induced Activation of Coagulation in Rabbits. Pathophysiology of Haemostasis and Thrombosis. 26(4). 179–186. 1 indexed citations
13.
Dickneite, Gerhard, D. Seiffge, Martin Reers, et al.. (1995). Pharmacological characterization of a new 4-amidinophenyl-alanine thrombin-inhibitor (CRC 220). Thrombosis Research. 77(4). 357–368. 20 indexed citations
14.
Stüber, Werner, et al.. (1995). Preparation and evaluation of PEG-bound thrombin inhibitors based on 4-amidinophenylalanine.. PubMed. 8(2). 78–85. 10 indexed citations
15.
Czech, Jörg, et al.. (1995). ANTITUMORAL ACTIVITY OF FLAVONE L-86-8275. International Journal of Oncology. 6(1). 31–6. 43 indexed citations
16.
Bosslet, Klaus, Jörg Czech, G. Seemann, Claude Monneret, & Dieter Hoffmann. (1994). Fusion protein mediated prodrug activation (FMPA) in vivo. Cell Biophysics. 24-25(1-3). 51–63. 9 indexed citations
17.
Sedlacek, H.H., et al.. (1994). Biochemical properties of recombinant human β-glucuronidase synthesized in baby hamster kidney cells. Biochemical Journal. 301(3). 821–828. 34 indexed citations
18.
Schorlemmer, H. U., H. Neubauer, Jörg Czech, & Gerhard Dickneite. (1993). Immunosuppressive therapy of organ-specific nephritic autoimmune diseases with 15-deoxyspergualin. Inflammation Research. 39(S1). C121–C124. 2 indexed citations
19.
Kaur, Gurmeet, M Stetler-Stevenson, Peter J. Worland, et al.. (1992). Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275. JNCI Journal of the National Cancer Institute. 84(22). 1736–1740. 301 indexed citations
20.
Bosslet, Klaus, Jörg Czech, Peter Lorenz, et al.. (1992). Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation. British Journal of Cancer. 65(2). 234–238. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey R. Simard Breakdown of academic impact, for papers by Zoltán Greff Breakdown of academic impact, for papers by Richard A. Norman Breakdown of academic impact, for papers by Ellen M. Dobrusin Breakdown of academic impact, for papers by Yiqun Li Breakdown of academic impact, for papers by Michael I. Walton Breakdown of academic impact, for papers by J A Double Breakdown of academic impact, for papers by Paul P. Tamburini Breakdown of academic impact, for papers by Melanie Valenti Breakdown of academic impact, for papers by R.J. Skene
Rankless by CCL
2026